Sanofi News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

13.09.16	Sanofi's Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone (GlobeNewswire)
12.09.16	Sanofi, Verily Life Sciences Launch JV For Comprehensive Diabetes Care (RTTNews)
12.09.16	Sanofi, Verily Life Launch JV To Develop Diabetes Management Platform (RTTNews)
12.09.16	Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform (GlobeNewswire)
06.09.16	Sanofi successfully prices EUR 3 billion bond issue (GlobeNewswire)
29.08.16	Regeneron, Sanofi Report Positive Data For Praluent - Quick Facts (RTTNews)
29.08.16	Sanofi and Regeneron Present Positive Phase 3 Investigational Data for Praluent® (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016 (GlobeNewswire)
22.08.16	Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation (RTTNews)
22.08.16	PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move (RTTNews)
19.08.16	Sanofi Provides Update on New Drug Application for Investigational Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide (GlobeNewswire)
14.08.16	Sanofi Reports Dengue Immunization Public Program In Paraná State Of Brazil (RTTNews)
13.08.16	Sanofi: Dengue Immunization Public Program in Paraná State of Brazil Set To Achieve WHO 2020 Ambition (GlobeNewswire)
01.08.16	Sanofi: EMA To Review Marketing Authorisation Application For Sarilumab (RTTNews)
29.07.16	Sanofi Q2 Profit Declines On Weak Sales; Maintains FY16 Outlook - Quick Facts (RTTNews)
28.07.16	FDA Approves Sanofi's Adlyxin For Treatment Of Adults With Type 2 Diabetes (RTTNews)
28.07.16	Sanofi Receives FDA Approval of AdlyxinTM for Treatment of Adults with Type 2 Diabetes (GlobeNewswire)
08.07.16	Sanofi: Availability of the Pre-quarterly Results Communication (GlobeNewswire)
06.07.16	Sanofi Pasteur Signs Research Agreement for Zika Vaccine (GlobeNewswire)
06.07.16	Medivation Reaches Confidentiality Agreements, Incl. With Sanofi (RTTNews)
05.07.16	Sanofi Enters into Confidentiality Agreement with Medivation and Will be Provided Due Diligence Access and Confidential Information (GlobeNewswire)
05.07.16	Regeneron Says Japan Approves Praluent To Treat Hypercholesterolemia (RTTNews)
05.07.16	Sanofi and Regeneron Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan (GlobeNewswire)
27.06.16	Sanofi and Boehringer Ingelheim have reached definitive agreements to swap Sanofi's Animal Health and Boehringer Ingelheim's Consumer Healthcare businesses (GlobeNewswire)
14.06.16	Sanofi Announces Expiration of Hart-Scott-Rodino Waiting Period Regarding Proposed Acquisition of Medivation (GlobeNewswire)
13.06.16	Sanofi Files Consent Solicitation To Remove And Replace Medivation's Board (RTTNews)
13.06.16	Sanofi Files Definitive Consent Solicitation to Remove and Replace Medivation's Board (GlobeNewswire)
13.06.16	Sanofi : LixiLan Diabetes Drug Trials Meet Primary Endpoints (RTTNews)
12.06.16	Sanofi Announces Positive Phase 3 Results for Investigational Titratable Fixed-Ratio Combination of Insulin Glargine and Lixisenatide (GlobeNewswire)
09.06.16	Sanofi Launches Action 2016, a Worldwide Employee Stock Purchase Plan (GlobeNewswire)
08.06.16	Sanofi Files Investor Presentation Regarding Proposed Acquisition of Medivation (GlobeNewswire)
06.06.16	Regeneron: Dupilumab With Topical Corticosteroids Superior To Treatment With TCS (RTTNews)
06.06.16	Sanofi and Regeneron Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Sever... (GlobeNewswire)
01.06.16	Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation's Board of Directors (GlobeNewswire)
26.05.16	No Pain, Only Gain For INNL, FDA Panel Backs SNY, Wait Continues For SRPT (RTTNews)
26.05.16	FDA Panel Recommends Approval Of Sanofi Treatment For Adults With Type2 Diabetes (RTTNews)
26.05.16	Sanofi: FDA Advisory Committee Recommends Approval of Sanofi Treatment for Adults with Type 2 Diabetes (GlobeNewswire)
25.05.16	Medivation Urges Stockholders To Reject Sanofi's Consent Solicitation (RTTNews)
25.05.16	Sanofi Files Consent Solicitation To Remove and Replace Medivation's Board (GlobeNewswire)
23.05.16	Sanofi Reports Changes To Its Executive Committee - Quick Facts (RTTNews)
23.05.16	Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020 (GlobeNewswire)
13.05.16	Sanofi Files For HSR Notification On Proposed Acquisition Of Medivation (RTTNews)
12.05.16	Sanofi Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Medivation (GlobeNewswire)
05.05.16	Sanofi Ready To Raise Medivation Bid, Threatens To Go Hostile Bid (RTTNews)
05.05.16	Sanofi Sends Letter to Medivation's Board of Directors (GlobeNewswire)
04.05.16	Sanofi: Annual General Shareholder Meeting of May 4, 2016 (GlobeNewswire)
01.05.16	Biotech Stocks Facing FDA Decision In May (RTTNews)
29.04.16	Sanofi Comments on Medivation's Rejection of Proposal (GlobeNewswire)
29.04.16	Sanofi Q1 Net Profit Up, But Sales Down; Backs 2016 Earnings View; Stock Dips (RTTNews)
29.04.16	Sanofi Q1 Profit Rises, Net Sales Down; Backs FY16 EPS View - Quick Facts (RTTNews)
28.04.16	Medivation Receives Non-binding Proposal From Sanofi - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’001.00	2.22 %	K V
Nestle	89.72	2.12 %	K V
Swisscom	519.50	1.56 %	K V
Novartis	100.92	1.46 %	K V
Roche Hldg G	307.00	1.42 %	K V
Logitech Intl	85.36	-0.97 %	K V
Sika	234.90	-1.43 %	K V
Alcon	80.54	-1.95 %	K V
Geberit	580.00	-2.09 %	K V
CieFinRichemont	164.85	-5.42 %	K V

mehr

07.03.25		Gute Stimmung in New York: Dow Jones zeigt sich am Freitagnachmittag fester
07.03.25		Dow Jones aktuell: Dow Jones notiert am Freitagmittag im Minus
07.03.25		Börse New York in Rot: S&P 500 am Freitagmittag in der Verlustzone
07.03.25		Angespannte Stimmung in Europa: Euro STOXX 50 legt schlussendlich den Rückwärtsgang ein
07.03.25		STOXX 50-Handel aktuell: STOXX 50 zum Ende des Freitagshandels leichter
07.03.25		Zuversicht in Zürich: SPI schlussendlich im Aufwind
07.03.25		Anleger in London halten sich zurück: FTSE 100 legt zum Ende des Freitagshandels den Rückwärtsgang ein

07.03.25

Gute Stimmung in New York: Dow Jones zeigt sich am Freitagnachmittag fester

07.03.25

Dow Jones aktuell: Dow Jones notiert am Freitagmittag im Minus

07.03.25

Börse New York in Rot: S&P 500 am Freitagmittag in der Verlustzone

07.03.25

Angespannte Stimmung in Europa: Euro STOXX 50 legt schlussendlich den Rückwärtsgang ein

07.03.25

STOXX 50-Handel aktuell: STOXX 50 zum Ende des Freitagshandels leichter

07.03.25

Zuversicht in Zürich: SPI schlussendlich im Aufwind